---
title: "Innovative drug concept stocks are repeatedly active, HitGen and CHENGDA PHARMA both rise over 10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249491973.md"
description: "HitGen and CHENGDA PHARMA both rose over 10%, while Baiotai, Sai Sheng Pharmaceutical, Livzon Pharmaceutical, Hitec Biopharma, Chenxin Pharmaceutical, and Jiankangyuan among others rose over 5%"
datetime: "2025-07-22T01:52:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249491973.md)
  - [en](https://longbridge.com/en/news/249491973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249491973.md)
---

# Innovative drug concept stocks are repeatedly active, HitGen and CHENGDA PHARMA both rise over 10%

HitGen and CHENGDA PHARMA both rose over 10%, while Baiotai, Saiseng Pharmaceutical, Livzon Pharmaceutical Group, Hitec Biopharma, Chenxin Pharmaceutical, and Jiankangyuan among others rose over 5%

### Related Stocks

- [688222.CN](https://longbridge.com/en/quote/688222.CN.md)
- [301201.CN](https://longbridge.com/en/quote/301201.CN.md)

## Related News & Research

- [Topstar Seeks Hong Kong IPO As Robotics Stock Frenzy Cools](https://longbridge.com/en/news/294047448.md)
- [China's Unitree flags US sales risk ahead of Shanghai IPO](https://longbridge.com/en/news/294392031.md)
- [Humanoid cleaning robots featuring Unitree's Chinese tech go viral in San Francisco](https://longbridge.com/en/news/294545505.md)
- [China warns of retaliation if US sticks with robot ban](https://longbridge.com/en/news/294286051.md)
- [Chinese Auto Parts Maker Haoneng Rises Against Market Trend on USD148 Million Robot Parts Factory Plan](https://longbridge.com/en/news/294346900.md)